| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |